ClearPoint Neuro (CLPT) Net Income towards Common Stockholders (2018 - 2026)
ClearPoint Neuro's Net Income towards Common Stockholders history spans 13 years, with the latest figure at -$7.8 million for Q4 2025.
- On a quarterly basis, Net Income towards Common Stockholders fell 44.56% to -$7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$25.5 million, a 35.03% decrease, with the full-year FY2025 number at -$25.5 million, down 35.03% from a year prior.
- Net Income towards Common Stockholders hit -$7.8 million in Q4 2025 for ClearPoint Neuro, down from -$5.9 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for CLPT hit a ceiling of -$2.5 million in Q1 2021 and a floor of -$7.8 million in Q4 2025.
- Historically, Net Income towards Common Stockholders has averaged -$4.9 million across 5 years, with a median of -$4.6 million in 2022.
- Biggest five-year swings in Net Income towards Common Stockholders: tumbled 174.41% in 2021 and later soared 38.19% in 2024.
- Tracing CLPT's Net Income towards Common Stockholders over 5 years: stood at -$4.1 million in 2021, then fell by 7.79% to -$4.5 million in 2022, then decreased by 5.3% to -$4.7 million in 2023, then decreased by 14.45% to -$5.4 million in 2024, then tumbled by 44.56% to -$7.8 million in 2025.
- Business Quant data shows Net Income towards Common Stockholders for CLPT at -$7.8 million in Q4 2025, -$5.9 million in Q3 2025, and -$5.8 million in Q2 2025.